Long Term Evaluation of Scapular-inserted Contraceptive Implants

Part of paid clinical trials in Aurora, Colorado.

Sponsor
Yale University
Study ID
NCT07201402
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Contraception

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

  • Scapular-site insertion of etonogestrel contraceptive implant — DRUG
    Participants will undergo insertion of the etonogestrel contraceptive implant subdermally over the inferior edge of their non-dominant scapula

Study Details

This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.

Key Dates

Start date
May 8, 2026
Status verified
May 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
62 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Reproductive age females
    All study participants will be reproductive age females interested in using an etonogestrel contraceptive implant

Primary Outcome Measure

Serum etonogestrel concentrations [ Time Frame: Every 6 months after insertion of the etonogestrel implant for up to 36 months (3 years) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of Colorado Anschutz Medical CampusAuroraColorado80045
Cara Clure, MD, MS
[email protected]
303-724-5000
Yale University School of MedicineNew HavenConnecticut06520
Aaron Lazorwitz, MD, PhD
[email protected]
203-737-7962

Find similar trials in Aurora, CO

By research site
University of Colorado Anschutz Medical Campus· Aurora, COYale University School of Medicine· New Haven, CT

Related Studies